Skip to main content
. 2017 May 19;2017(5):CD011598. doi: 10.1002/14651858.CD011598.pub2

Bastow 1983a.

Methods Randomised clinical trial, hospital in UK
Participants 122 hospitalised adults with fractured neck of femur and assessed as thin (1 ‐ 2 SDs below the mean), at nutritional risk due to being frail elderly with hip fracture
Only women
 Mean age = 80 years
Exclusion criteria: severe dementia or serious concomitant physical disorders, e.g. stroke
Interventions Experimental group: an overnight feed of 1 litre Clinifeed Iso (4 ‐ 2 MJ (1000 kcal), including 28 g protein). It was started within 5 days of operation and delivered over 8 hrs each night through a fine bore soft nasogastric tube using a peristaltic pump. Tube‐feeding was continued until the adult was discharged from the ward, did not tolerate the tube or died.(n = 39)
Control group: no intervention(n = 35)
Co‐interventions: both control and tube‐fed adults ate a normal ward diet during the day and were given free access to snacks and drinks.
Outcomes Weight, upper arm circumference, triceps skinfold thickness, mortality, food intake, length of hospital stay, mobility, plasma protein
Study dates Not stated
Notes Same trial as Bastow 1983b but with the participants characterised as 'thin'. We could not obtain any contact information on the author.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not described
Allocation concealment (selection bias) Unclear risk Not described
Blinding of participants and personnel (performance bias) 
 All outcomes Unclear risk Not described
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk Not described
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk The number of participants with incomplete data was not reported.
Selective reporting (reporting bias) Unclear risk No protocol could be obtained and the trial did not report all‐cause mortality and serious adverse events.
For‐profit bias High risk One of the authors was supported by a grant from Roussell Laboratories Ltd.
Other bias Low risk The trial appeared to be free of other components that could put it at risk of bias.